MARASCA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.804
AS - Asia 14.226
EU - Europa 12.001
SA - Sud America 1.844
AF - Africa 288
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 22
Totale 58.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.384
GB - Regno Unito 4.404
HK - Hong Kong 3.687
SG - Singapore 3.547
CN - Cina 3.340
IT - Italia 1.900
VN - Vietnam 1.509
BR - Brasile 1.410
SE - Svezia 1.221
DE - Germania 1.028
FI - Finlandia 920
RU - Federazione Russa 571
UA - Ucraina 526
FR - Francia 444
TR - Turchia 431
KR - Corea 308
IN - India 289
ID - Indonesia 221
BG - Bulgaria 212
CA - Canada 207
BD - Bangladesh 173
AR - Argentina 134
NL - Olanda 128
IQ - Iraq 107
MX - Messico 106
JP - Giappone 102
ES - Italia 89
IE - Irlanda 88
EC - Ecuador 74
PL - Polonia 73
ZA - Sudafrica 71
PK - Pakistan 70
CZ - Repubblica Ceca 67
AE - Emirati Arabi Uniti 60
CL - Cile 59
BE - Belgio 55
AT - Austria 52
PH - Filippine 51
AU - Australia 49
VE - Venezuela 48
CO - Colombia 46
MA - Marocco 44
MY - Malesia 38
LT - Lituania 37
KE - Kenya 34
UZ - Uzbekistan 34
SA - Arabia Saudita 33
TN - Tunisia 29
DZ - Algeria 26
EG - Egitto 26
PY - Paraguay 26
RO - Romania 26
IR - Iran 24
JM - Giamaica 24
AZ - Azerbaigian 22
JO - Giordania 20
BZ - Belize 19
CH - Svizzera 18
TW - Taiwan 18
IL - Israele 17
SK - Slovacchia (Repubblica Slovacca) 17
BO - Bolivia 16
CR - Costa Rica 16
NP - Nepal 16
EU - Europa 15
PE - Perù 15
DK - Danimarca 14
ET - Etiopia 14
UY - Uruguay 14
PT - Portogallo 13
RS - Serbia 13
AL - Albania 12
LB - Libano 11
SI - Slovenia 11
DO - Repubblica Dominicana 10
BY - Bielorussia 9
CY - Cipro 9
KZ - Kazakistan 9
QA - Qatar 9
SN - Senegal 9
TH - Thailandia 9
GR - Grecia 8
OM - Oman 8
PS - Palestinian Territory 8
BH - Bahrain 7
LK - Sri Lanka 7
LV - Lettonia 7
SY - Repubblica araba siriana 7
EE - Estonia 6
HN - Honduras 6
KG - Kirghizistan 6
KW - Kuwait 6
MD - Moldavia 6
NG - Nigeria 6
PA - Panama 6
PR - Porto Rico 6
AO - Angola 5
GT - Guatemala 5
HU - Ungheria 5
MK - Macedonia 5
Totale 58.157
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.659
Fairfield 3.248
Southend 3.187
Ashburn 3.021
Santa Clara 2.358
Singapore 2.224
Woodbridge 1.877
Ann Arbor 1.651
Houston 1.491
Chandler 1.447
Seattle 1.254
Wilmington 1.069
Cambridge 1.018
Hefei 984
Jacksonville 975
Dearborn 839
San Jose 785
Nyköping 746
Helsinki 703
London 648
Beijing 587
Ho Chi Minh City 502
Los Angeles 499
Chicago 459
Modena 426
New York 364
The Dalles 333
Hanoi 318
Council Bluffs 307
San Diego 302
Seoul 292
Princeton 247
Buffalo 238
Izmir 228
Sofia 209
Lauterbourg 193
Milan 190
Eugene 189
Munich 185
Salt Lake City 184
Moscow 157
Jakarta 155
Shanghai 132
São Paulo 121
Fremont 112
Dallas 109
Frankfurt am Main 97
Tampa 97
Bremen 90
Bologna 88
Columbus 82
Dublin 82
Elk Grove Village 80
Rome 80
Orem 79
Redwood City 79
Tokyo 78
Da Nang 70
Phoenix 67
Boardman 66
Des Moines 65
Haiphong 63
Dong Ket 57
Toronto 57
Warsaw 53
Brooklyn 52
Montreal 52
Atlanta 51
Brussels 50
Nuremberg 50
Chennai 49
Falls Church 49
Guangzhou 49
Baghdad 45
Lancaster 45
Norwalk 43
Brno 42
Kent 42
Rio de Janeiro 41
Denver 40
Miami 40
Kunming 36
Stockholm 36
Philadelphia 35
San Francisco 33
Turku 33
Amsterdam 31
Johannesburg 31
Kilburn 31
Nanjing 30
Tashkent 30
Dulles 29
Parma 29
Redondo Beach 29
Belo Horizonte 28
Boston 28
Las Vegas 28
Poplar 28
Sterling 28
Vienna 28
Totale 42.973
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 825
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 587
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 574
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 418
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 412
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 408
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 407
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 399
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 391
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 388
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 368
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 367
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 363
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 355
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 352
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 352
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 348
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 342
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 341
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 337
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 337
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 328
Mucorales-specific T cells in patients with hematologic malignancies 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 324
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 320
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 318
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 318
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 317
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 317
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience 315
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 315
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 315
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 309
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 306
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 306
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 305
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia 305
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 305
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
The genetics of nodal marginal zone lymphoma 303
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 303
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 301
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 298
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 298
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 294
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 293
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 292
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 291
P53 GENE POINT MUTATIONS IN RELATION TO P53 NUCLEAR-PROTEIN ACCUMULATION IN COLORECTAL CANCERS 290
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 290
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 290
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 290
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 289
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 289
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 287
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 285
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 284
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage 282
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 282
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 281
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 281
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 281
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 280
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 280
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 279
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance 278
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 277
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 276
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 276
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 276
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 274
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia 273
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival 271
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 271
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 271
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 270
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 269
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. 268
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. 268
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 267
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia 267
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 265
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 265
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 263
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 261
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 260
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 260
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Randomized phase 2 study: Elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM 258
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 257
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 256
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene 255
Late-appearing PML/RAR alpha fusion transcript with coincidental t(12;13)(p13.2;q14) in acute promyelocytic leukemia lacking the t(15;17) cytogenetic anomaly 254
Totale 31.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 226.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 226.349
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021759 0 0 0 0 0 0 0 0 0 0 397 362
2021/20224.275 197 548 517 206 99 235 259 192 398 307 698 619
2022/20234.255 503 482 325 374 579 570 81 445 488 51 190 167
2023/20242.972 104 162 172 272 562 270 349 452 54 68 188 319
2024/202510.787 313 123 141 682 1.580 1.278 624 450 2.867 445 985 1.299
2025/202617.026 1.227 1.274 1.683 2.054 2.619 1.259 2.284 924 1.739 1.613 350 0
Totale 58.767